Clinical Trials Logo

Clinical Trial Summary

Background: PICC-related thrombosis have shown a slightly different pattern of frequency and risk factors, compared with traditional CVC; because of the increasing diffusion of PICCs, they are becoming a somehow independent pathology, still under investigation; no pharmacological prevention has proved to be effective. Aim of this study is to estimate the cumulative incidence of thrombosis in a cohort of patients carrying a PICC-line CVC, monitored to allow an early detection and prevention of complications related to the presence of asymptomatic deep venous thrombosis, and to explore the role of several potential risk factors.

Methods: in a prospective observational cohort we will enroll 150 consecutive patients having a PICC inserted by our team; clinical characteristics, comorbidities and main features of catheter positioning procedure will be registered; patients will be followed with clinical and echographic scheduled controls, weekly for the first month, then monthly; patients with PRDVT will be treated with LMWH and recontrolled weekly until removal of catheter


Clinical Trial Description

All PICCs are positioned by trained physicians and nurses, after ultrasonographic screening of the whole upper limbs venous district, axillary, subclavian and jugular veins for detecting possible pre-existing thrombosis; positioning is performed with real-time ultrasonography guide with a portable device. Patients are recontrolled one week after positioning; patients who report pain, swelling, fever, skin colour changes, exit site tenderness, or any symptom suspected for thrombosis or infection, are immediately seen. A duplex ultrasound complete examination of the upper limb and neck vessels is performed, and at the same time the whole arm and the exit site is inspected to exclude infections; diagnostic criteria for DVT include incompressibility of the vein and direct visualisation of PICC-surrounding thrombus; in uncertain cases, a doppler examination is performed.If the examination is negative for thrombosis, further controls are performed at 2,3,4 weeks after positioning, then once a month.If a DVT is detected, we register the position and extension of the thrombus, and its main characteristics (clot, mural or occlusive thrombosis); the catheter is left in place and a therapy is prescribed with LMWH at full doses, according with ACCP guidelines 2008 (confirmed in 2012 edition). Then, the patient is recontrolled weekly until removal of the catheter. ;


Study Design

Observational Model: Cohort, Time Perspective: Prospective


Related Conditions & MeSH terms


NCT number NCT01779999
Study type Observational
Source University of Turin, Italy
Contact
Status Completed
Phase N/A
Start date June 2010
Completion date June 2012

See also
  Status Clinical Trial Phase
Completed NCT04503135 - Catheter Associated Asymptomatic Thrombosis in Intensive Care Unit
Completed NCT03766828 - Dialysis Catheter Placement in Patients With Thoracic Central Venous Occlusion
Completed NCT01708850 - Study in Cancer Patients With Central Line Associated Clots in the Upper Extremity Treated With Rivaroxaban (Catheter 2) Phase 4
Recruiting NCT03100071 - Central Venous Catheter (CVC) Associated Deep Vein Thrombosis (DVT) in Cancer Patients
Recruiting NCT04548713 - CLiCK in the Critical Care Unit N/A
Completed NCT03506815 - Thromboprophylaxis With Rivaroxaban In Patients With Malignancy and Central Venous Lines Phase 3
Completed NCT04767113 - Continuous Heparin Infusion to Prevent Catheter-related Thrombosis N/A
Not yet recruiting NCT04774588 - HoloStream Study - Video Capture Device Usage N/A
Recruiting NCT05033314 - THromboprophylaxis In Sickle Cell Disease With Central Venous Catheters (THIS) Phase 3
Recruiting NCT03157245 - Incidence of Deep Vein Thrombosis on Central Venous Catheters in the Post Operative Period of Carcinologic Surgery N/A
Enrolling by invitation NCT05188339 - The Effectiveness and Safety of 4% Sodium Citrate as a Lock Solution in Central Venous Hemodialysis Catheter Phase 2/Phase 3
Not yet recruiting NCT05455866 - Central Venous Catheter-related Complications in Patients Under Anticancer Treatment
Not yet recruiting NCT02264964 - Duration and Adverse Events of Non-cuffed Catheter in Patients With Hemodialysis N/A
Enrolling by invitation NCT03841240 - The Central Venous Catheter Related Complications in Critically Ill Patients
Completed NCT04302376 - Thrombotic Complications After Central Venous Catheterization
Completed NCT03327376 - Daily Ultrasound-screening for CVC-related Thrombosis
Recruiting NCT04535206 - The Relationship Between the Lack of AT-Ⅲ, PC, PS Activity and PICC-related Thrombosis
Completed NCT03672006 - t-PA Prophylaxis to Prevent Catheter-associated Thrombosis and Infection Phase 2